Contrast-enhanced MR imaging assessment of tumor capillary permeability: effect of irradiation on delivery of chemotherapy.
about
Openings between defective endothelial cells explain tumor vessel leakinessDynamic Contrast Magnetic Resonance Imaging (DCE-MRI) and Diffusion Weighted MR Imaging (DWI) for Differentiation between Benign and Malignant Salivary Gland Tumors.Measurement of blood-brain barrier permeability with t1-weighted dynamic contrast-enhanced MRI in brain tumors: a comparative study with two different algorithms.Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics.Applications of magnetic resonance in model systems: cancer therapeuticsDynamic image interpretation of MRI of the breast.Peroxiredoxin 1 controls prostate cancer growth through Toll-like receptor 4-dependent regulation of tumor vasculatureApplications of molecular imaging.Vascular permeability during antiangiogenesis treatment: MR imaging assay results as biomarker for subsequent tumor growth in rats.Dual-energy micro-computed tomography imaging of radiation-induced vascular changes in primary mouse sarcomas.Perfusion parameters as potential imaging biomarkers for the early prediction of radiotherapy response in a rat tumor model.MR imaging biomarkers for evaluating therapeutic effects shortly after near infrared photoimmunotherapy.In vivo characterization of tumor vasculature using iodine and gold nanoparticles and dual energy micro-CT.Glioblastoma Induces Vascular Dysregulation in Nonenhancing Peritumoral Regions in HumansMagnetic resonance imaging (MRI) contrast agents for tumor diagnosis.Assessment of neovascular permeability in a pancreatic tumor model using dynamic contrast-enhanced (DCE) MRI with contrast agents of different molecular weights.Tumor microvascular changes in antiangiogenic treatment: assessment by magnetic resonance contrast media of different molecular weights.Assessing tumor angiogenesis using macromolecular MR imaging contrast media.Physiologic measurements by contrast-enhanced MR imaging: expectations and limitations.Investigation of longitudinal vascular changes in control and chemotherapy-treated tumors to serve as therapeutic efficacy predictors.A new polysaccharide macromolecular contrast agent for MR imaging: biodistribution and imaging characteristics.Dynamic contrast-enhanced MR perfusion imaging of head and neck tumors at 3 Tesla.Magnetic resonance characterization of tumor microvessels in experimental breast tumors using a slow clearance blood pool contrast agent (carboxymethyldextran-A2-Gd-DOTA) with histopathological correlation.MRI assessment of microvascular characteristics in experimental breast tumors using a new blood pool contrast agent (MS-325) with correlations to histopathology.Assessment of a rapid clearance blood pool MR contrast medium (P792) for assays of microvascular characteristics in experimental breast tumors with correlations to histopathology.Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor.Comparison of albumin-(Gd-DTPA)30 and Gd-DTPA-24-cascade-polymer for measurements of normal and abnormal microvascular permeability.Comparison of gadopentetate dimeglumine and albumin-(Gd-DTPA)30 for microvessel characterization in an intracranial glioma model.Quantitative analysis of permeability for glioma grading using dynamic contrast-enhanced magnetic resonance imaging.Pharmacological and physical vessel modulation strategies to improve EPR-mediated drug targeting to tumors.MR factor analysis: improved technology for the assessment of 2D dynamic structures of benign and malignant salivary gland tumors.Assessing permeability alterations of the blood-bone marrow barrier due to total body irradiation: in vivo quantification with contrast enhanced magnetic resonance imaging
P2860
Q24681507-2CE31CE2-61B4-42C5-A7D0-0F2BD723425BQ31033142-DEC75949-E5F9-4E0F-A683-3C6730EC85DEQ33711249-FC60497F-409D-4FB3-8EEA-8F38CB72E630Q33847006-235E065F-BA68-4384-AA68-D6F5719ED6BBQ33995811-6A703F86-67A7-4C2E-A051-59AECBEA5E8BQ34097698-7084E9C5-743C-41D4-BDFB-12E2984826D3Q34793013-D22DF684-2CB9-48E8-85EF-91608A446799Q35082412-84F39D1B-5C38-400A-BCF2-0E82E4221680Q35581064-DD1ED005-C839-4B1D-AB0B-7F1BBC35B77CQ36764589-FD8B4C7D-937E-4687-8442-987F1330700CQ36878999-8BF975D5-B36E-4BB9-9CBF-B394DEB03412Q37086258-982B428C-1D1C-48C0-BDBC-DC7C24F3391FQ37102305-B91A0A16-6C56-4D27-B66A-6F4E2662A016Q37585900-EDC5819A-5690-4048-8CD6-4905B6632130Q38090392-313AEFE5-D6F4-4055-A8A8-7E30A21607DCQ39543749-F97CF0AD-70B6-46FB-AC26-03469132B830Q40540980-B90D1FC6-6035-46E9-BF7F-04CA63330C92Q41352765-41185958-22DC-43BD-9A78-E34E1CE6AC5EQ41352783-0F2B0688-BAE6-4B1B-B287-DEF13E833B10Q41609320-5C0635A4-3888-43C8-86DB-17E78212242CQ41742671-7A2DDDD5-482D-4CE4-B10B-F8693FA7A46DQ43410399-67EA9BD8-A0FD-4E76-80FE-0EAEF442C0FAQ45936684-41AC03A1-6B42-4546-8CDE-877A91F25F50Q46089577-12546B7B-7EE6-4CFA-BE79-DDA4CCFBBE20Q46103337-B1FCADCD-6F38-4A30-9F80-2E3910B9371DQ46319983-275CD2F5-ACDF-48BC-85BC-89E9BEB56DD1Q46381491-ADFF1993-FDD5-4EB4-A411-DF12B5F9246FQ46464103-B6AABA51-4384-48D8-854F-203A536758FAQ47133042-6D2E2FA4-C272-4780-B363-008172B47E84Q48724706-5EFF8CA8-BF9E-46C0-8E07-C885559E74E9Q53414243-6BD7B1D4-402C-4E11-B116-50B58B061A1BQ57188857-6C03D00B-8126-4D39-8A98-2FCC7C0AD109
P2860
Contrast-enhanced MR imaging assessment of tumor capillary permeability: effect of irradiation on delivery of chemotherapy.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Contrast-enhanced MR imaging a ...... n on delivery of chemotherapy.
@en
Contrast-enhanced MR imaging a ...... n on delivery of chemotherapy.
@nl
type
label
Contrast-enhanced MR imaging a ...... n on delivery of chemotherapy.
@en
Contrast-enhanced MR imaging a ...... n on delivery of chemotherapy.
@nl
prefLabel
Contrast-enhanced MR imaging a ...... n on delivery of chemotherapy.
@en
Contrast-enhanced MR imaging a ...... n on delivery of chemotherapy.
@nl
P2093
P1433
P1476
Contrast-enhanced MR imaging a ...... n on delivery of chemotherapy.
@en
P2093
Roberts TP
Schwickert HC
van Dijke CF
P304
P356
10.1148/RADIOLOGY.198.3.8628889
P407
P577
1996-03-01T00:00:00Z